Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hirudins: antithrombin anticoagulants.

K A Stringer1, J Lindenfeld

  • 1University of Colorado Health Sciences Center, School of Pharmacy, Denver 80262.

The Annals of Pharmacotherapy
|December 1, 1992
PubMed
Summary

Hirudin, a potent anticoagulant, shows promise for managing patients needing blood thinners. Further clinical trials are ongoing to determine its exact role in therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.

Circulation·2004
Same author

Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.

Journal of the American College of Cardiology·2001
Same author

A call for pharmacists to improve the care of patients with myocardial infarction.

Pharmacotherapy·2001
Same author

An institution-specific heparin titration nomogram: development, validation, and assessment of compliance.

Pharmacotherapy·2001
Same author

Report from the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001.

Circulation·2001
Same author

Identification of risk factors for increased cost, charges, and length of stay for cardiac patients.

The Annals of thoracic surgery·2000

Area of Science:

  • Pharmacology
  • Biochemistry
  • Clinical Medicine

Background:

  • Hirudin is a direct thrombin inhibitor with potent anticoagulant properties.
  • Its unique mechanism of action differs from traditional anticoagulants like heparin.
  • Understanding hirudin's profile is crucial for advancing antithrombotic therapies.

Purpose of the Study:

  • To comprehensively review the chemistry, pharmacology, clinical data, and adverse effects of hirudin.
  • To assess the current evidence supporting hirudin's use as an anticoagulant.
  • To identify the potential impact of hirudin on anticoagulant therapy.

Main Methods:

  • Literature search of MEDLINE and scientific abstracts.
  • Inclusion of human studies, supplemented by relevant animal data (pharmacokinetics, preclinical efficacy).
  • Evaluation focused on human trials, emphasizing data from clinical investigations.

Main Results:

  • Hirudin demonstrates powerful anticoagulant effects in preliminary studies.
  • Limited human data is available, with ongoing trials comparing hirudin to heparin.
  • The full clinical impact and optimal use in specific patient groups remain under investigation.

Conclusions:

  • Hirudin represents a novel anticoagulant agent with potential to significantly impact therapy.
  • While promising, its definitive role in patient management is yet to be established.
  • Ongoing clinical trials are essential to fully characterize hirudin's therapeutic value and safety profile.

Related Experiment Videos